WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced two major equity financing agreements totaling up to ...

Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, ...

Windtree Therapeutics secures $520M to pivot into a BNB-focused crypto treasury strategy, marking a bold move for corporate ...

After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, Warrington-based Windtree Therapeutics ...

Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...

Biotech firm Windtree Therapeutics secures $520 million funding to build massive BNB treasury as first Nasdaq-listed company.

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC) agreement and an additional $20 million stock purchase deal, with total ...

Crypto exchange Kraken will custody and manage BNB assets for Windtree Therapeutics' crypto treasury plan tied to Binance ...

"We are excited to incorporate these new facilities to enable our future BNB acquisitions as part of our BNB treasury strategy," stated Jed Latkin, CEO of Windtree. "Pending stockholder approval, the ...

Windtree said it aims to become the first NASDAQ-listed company to offer direct exposure to BNB. The treasury strategy ...